2025 MCM | New and Evolving Directions in the Treatment of HER2 Positive Breast Cancer

2025 MCM | New and Evolving Directions in the Treatment of HER2 Positive Breast Cancer

0% Complete

Course Content

Credits

  • AMA PRA Category 1 Creditâ„¢Non-CME

Course Details

Duration
0.00 hour
Released
Jun 24, 2025
Last Review
Jun 24, 2025
Expires
Jun 24, 2026

Target Audience

Physicians

Nurses

Pharmacists

Physician Associates

Faculty & Disclosure

Faculty

Mark Pegram, MD

Disclosure

Mark Pegram, MD

Accreditation

NA